MedTrace Logo

CARESS: An Investigation of Effects of CARESS

NCT03758027 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2020-08-17

No results posted yet for this study

Summary

The purpose of this research is to study the efficacy of an intervention that could interrupt the cycle of emotion dysregulation as it relates to cravings and negative emotions for those with problematic substance use behaviors. This will be a quantitative randomized control trial study with data collection at three points: pre-intervention, post-intervention, and same-day follow up. This study will be conducted at the Inova Behavioral Health Merrifield Center. Inova's addictions services program is the CATS program (formerly comprehensive addiction treatment services), which provides therapeutic interventions for those managing substance use disorders. The focus of measurement will be about the current state of the participant, and not a cumulative status. This one-session intervention. The goal is to have 96 participants in the study, 48 in each of the two groups.

Conditions

Interventions

BEHAVIORAL

CARESS

The goals of each component are as follows: * Communicate alternatively - a method to bring the brain back and remove the individual from his/her limbic system; * Release endorphins - a release for the internal stress created by the emotion; and * Self-soothe - a method of quelling and containing.

BEHAVIORAL

Isometric Exercise

5-minute protocol for cravings management and affect regulation

Sponsors & Collaborators

  • Inova Health Care Services

    lead OTHER

Principal Investigators

  • Maria C Hadjiyane, MA, MS · Sr. Director Behavioral Health Adult Ambulatory Services

  • Sylvia Marotta-Walters, PhD · Chair, Graduate School of Education and Human Development

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-06-30
Completion
2019-11-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03758027 on ClinicalTrials.gov